Literature DB >> 28891343

Current and future contraceptive options for women living with HIV.

Rena C Patel1, Elizabeth A Bukusi2,3, Jared M Baeten4.   

Abstract

INTRODUCTION: Among women living with HIV, half of the pregnancies are unintended. Effective contraception can prevent unintended pregnancies and consequently reduce maternal mortality and perinatal transmission of HIV. While contraceptive options available for all women also apply to women living with HIV, specific considerations exist to the use of contraception by women living with HIV. AREAS COVERED: First, general principles guiding the use of contraception among women living with HIV are discussed, such as choice, method mix, relative effectiveness, and drug-drug interactions. Second, a detailed discussion of each contraceptive method and issues surrounding the use of that method, such as drug-drug interactions, follows. Third, future contraceptive options in advanced development for use by women or men are briefly discussed. EXPERT OPINION: Contraceptive methods available to all women should also be accessible to women living with HIV. When the relative effectiveness of a contraceptive method is reduced, for example due to drug-drug interactions with antiretrovirals, the method should still be made available to women living with HIV with the appropriate information sharing and counseling. Greater research on various aspects of contraceptive use by women living with HIV and more comprehensive testing of co-administration of hormonal contraceptives and common medications used by these women are warranted.

Entities:  

Keywords:  Female contraception; antiretrovirals; drug-drug interactions; male contraception; resource-limited settings; women living with HIV

Mesh:

Substances:

Year:  2017        PMID: 28891343      PMCID: PMC5963879          DOI: 10.1080/14656566.2017.1378345

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  92 in total

1.  Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.

Authors:  Mira Harrison-Woolrych; Richard Hill
Journal:  Contraception       Date:  2005-04       Impact factor: 3.375

2.  The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.

Authors:  Oskari Heikinheimo; Päivi Lehtovirta; Jukka Suni; Jorma Paavonen
Journal:  Hum Reprod       Date:  2006-07-31       Impact factor: 6.918

3.  Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.

Authors:  Catherine S Todd; Jennifer Deese; Meng Wang; David Hubacher; Markus J Steiner; Sheila Otunga; Lut Van Damme
Journal:  Contraception       Date:  2014-10-22       Impact factor: 3.375

4.  Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.

Authors:  Mary A Vogler; Kristine Patterson; Lori Kamemoto; Jeong-Gun Park; Heather Watts; Francesca Aweeka; Karin L Klingman; Susan E Cohn
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.

Authors:  Erica Schlesinger; Daniel Johengen; Ellen Luecke; Ginger Rothrock; Ian McGowan; Ariane van der Straten; Tejal Desai
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

6.  High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents.

Authors:  Nadia Kancheva Landolt; Torsak Bunupuradah; Pope Kosalaraksa; Sasiwimol Ubolyam; Narukjaporn Thammajaruk; Serge Cremers; Roseann Zott; Stephen Kerr; Jintanat Ananworanich
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

7.  A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.

Authors:  Sigrid von Eckardstein; Gabriela Noe; Vivian Brache; Eberhard Nieschlag; Horacio Croxatto; Francisco Alvarez; Alfred Moo-Young; Irving Sivin; Narender Kumar; Margaret Small; Kalyan Sundaram
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

8.  Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services.

Authors:  Diane Cooper; Jennifer Moodley; Virginia Zweigenthal; Linda-Gail Bekker; Iqbal Shah; Landon Myer
Journal:  AIDS Behav       Date:  2009-04-03

9.  Integration of family planning services into HIV care and treatment in Kenya: a cluster-randomized trial.

Authors:  Daniel Grossman; Maricianah Onono; Sara J Newmann; Cinthia Blat; Elizabeth A Bukusi; Starley B Shade; Rachel L Steinfeld; Craig R Cohen
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

10.  Women living with HIV in South Africa and their concerns about fertility.

Authors:  Mzikazi Nduna; Lindiwe Farlane
Journal:  AIDS Behav       Date:  2009-03-20
View more
  4 in total

1.  Brief Report: Incidence and Correlates of Pregnancy in HIV-Positive Kenyan Sex Workers.

Authors:  Erica M Lokken; George Wanje; Barbra A Richardson; Esther Mutunga; Kate S Wilson; Walter Jaoko; John Kinuthia; Raymond Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2020-09-01       Impact factor: 3.771

2.  Ten Years of Experience in Contraception Options for Teenagers in a Family Planning Center in Thrace and Review of the Literature.

Authors:  Panagiotis Tsikouras; Dorelia Deuteraiou; Anastasia Bothou; Xanthi Anthoulaki; Anna Chalkidou; Eleftherios Chatzimichael; Fotini Gaitatzi; Bachar Manav; Zacharoula Koukoul; Stefanos Zervoudis; Grigorios Trypsianis; George Galazios
Journal:  Int J Environ Res Public Health       Date:  2018-02-15       Impact factor: 3.390

Review 3.  Clinical Pharmacology of Hormonal Emergency Contraceptive Pills.

Authors:  Celia M J Matyanga; Blessing Dzingirai
Journal:  Int J Reprod Med       Date:  2018-10-04

4.  Low Rates of Contraception Use in Women With Human Immunodeficiency Virus.

Authors:  Manasa Bhatta; Aihua Bian; Jamison Norwood; Bryan E Shepherd; Imani Ransby; Jeffrey Nelson; Megan Turner; Timothy R Sterling; Jessica L Castilho
Journal:  Open Forum Infect Dis       Date:  2022-03-08       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.